Grifols stock pre-market: EUR 9.84, prior close EUR 9.87
Published on 10/08/2026 at 07:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Grifols stock was EUR 9.84 in pre-market trading at Lang & Schwarz at 7:52 a.m. CEST on October 8, 2026, down EUR 0.03, or 0.30 percent, against the EUR 9.87 prior close at Lang & Schwarz on October 7, 2026.
Pre-market trading
Lang & Schwarz showed a bid of EUR 9.79 and an ask of EUR 9.89. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Grifols stock.
Canadian plasma operations
Health Canada suspended the license of Grifols’s Taylor Avenue plasma center in Winnipeg effective immediately in September, citing concerns about the site’s quality management system. The regulator said the company had not effectively implemented corrective and preventive actions, according to CBC News.
Grifols said the suspension did not affect current operations because plasma collection had already been paused at the facility. The company said it was working with Health Canada on a reopening plan and had reviewed operations, including staff retraining and improvements to procedures and quality systems, Reuters reported.
Grifols operates plasma collection centers in Canada, including two in Winnipeg. Health Canada said it would verify the company’s compliance before collection resumes, according to CBC News.
